Table 1 The characteristics of GWAS studies on the exposures and outcomes
Exposure | Consortium | Total population | Cases/controls | Ethnicity |
|---|---|---|---|---|
Age at menarche | Within family GWAS consortium | 29,346 | NA | European |
Age at first sexual intercourse | NA | 397,338 | NA | European |
Age at first birth | NA | 418,758 | NA | European |
Age at last live birth | Neale Lab | 123,676 | NA | European |
Age at menopause | ReproGen | 69,360 | NA | European |
Outcome | Consortium | Total population | Cases/controls | Ethnicity |
Female genital prolapse | NA | 78,061 | 9,092/ 68,969 | European |
Stress urinary incontinence | MRC-IEU | 463,010 | 4,340/ 458,670 | European |